Similar articles

• [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].

  Beez M, Fresenius E. Beez M, et al. Infusionsther Klin Ernahr. 1979 Aug;6(4):263-4. Infusionsther Klin Ernahr. 1979. PMID: 90653 German. No abstract available.
• [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].

  [No authors listed] [No authors listed] Infusionsther Klin Ernahr. 1978 Apr;5(2):118-9. Infusionsther Klin Ernahr. 1978. PMID: 77255 German. No abstract available.
• [Antishock blood substitute based on hydroxyethyl starch].

  Polushina TV, Prostakova TM, Bogino NA. Polushina TV, et al. Probl Gematol Pereliv Krovi. 1980 Mar;25(3):40-4. Probl Gematol Pereliv Krovi. 1980. PMID: 6154296 Russian. No abstract available.
• Hydroxyethyl starch.

  Thompson WL Jr. Thompson WL Jr. Prog Clin Biol Res. 1978;19:283-92. Prog Clin Biol Res. 1978. PMID: 78499 Review. No abstract available.
• Clinical pharmacology of hydroxyethyl starches.

  Mishler JM 4th. Mishler JM 4th. Rev Fr Transfus Immunohematol. 1980;23(3):283-98. Rev Fr Transfus Immunohematol. 1980. PMID: 6157397 Review. No abstract available.